Generalized Anxiety Disorder Market – Forecast (2021-2026)
1. Generalized Anxiety Disorder Market – Scope & Methodology
1.1 Market Segmentation
1.2 Assumptions
1.3 Research Methodology
1.4 Primary Sources
1.5 Secondary Sources
2. Generalized Anxiety Disorder Market- Executive Summary
2.1 Market Size & Forecast – (2020 - 2026) ($M/$B)
2.2 Key Trends & Insights
2.3 Market Share Analysis
2.4 Strategy & Development Scenario
2.6 Market Life Cycle
3. Generalized Anxiety Disorder Market -Landscape
3.1 Value Chain Analysis
3.2 Market Drivers
3.3 Market Restraints/Challenges
3.4 Market Opportunities
3.5 Porter Five Force Model
4. Generalized Anxiety Disorder Market, By Therapeutics Type - Market Size, Forecast, Trends & Insights
4.1 Antidepressant
4.1.1 Selective Serotonin Reuptake Inhibitor (SSRI)
4.1.2 Serotonin Norepinephrine Reuptake Inhibitor (SNRI)
4.2 Benzodiazepines
4.2.1 Alprazolam
4.2.2 Chlordiazepoxide
4.2.3 Diazepam
4.2.4 Lorazepam
4.3 Others (Buspirone)
5. Generalized Anxiety Disorder Market, By Geography - Market Size, Forecast, Trends & Insights
5.1 North America
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Europe
5.2.1 Italy
5.2.2 Spain
5.2.3 Russia
5.2.4 Germany
5.2.5 UK
5.2.6 France
5.2.7 Rest of Europe
5.3 Asia Pacific
5.3.1 Japan
5.3.2 South Korea
5.3.3 China
5.3.4 India
5.3.5 Australia & New Zealand
5.3.6 Rest of Asia-Pacific
5.4 Rest of the World
5.4.1 South America
5.4.2 Middle East
5.4.3 Africa
6. Generalized Anxiety Disorder Market- Company Profiles – (Overview, Product Portfolio, Financials, Developments)
6.1 Company 1
6.2 Company 2
6.3 Company 3
6.4 Company 4
6.5 Company 5
6.6 Company 6
6.7 Company 7
6.8 Company 8
6.9 Company 9
6.10 Company 10
2850
5250
4500
1800